Table 1.
Correlation between the density of LAMC1 at gastric cancer and clinicopathologic parameters
| Parameters | N (%) | LAMC1 expression | ||
|---|---|---|---|---|
| High | Low | P | ||
| Gender | 0.0628 | |||
| Male | 64 (71.11) | 28 | 36 | |
| Female | 26 (28.29) | 17 | 9 | |
| Age (years) | 0.3894 | |||
| <60 | 36 (40.00) | 16 | 20 | |
| ≥60 | 54 (60.00) | 29 | 25 | |
| T stage | 0.0112 | |||
| T1-2 | 20 (22.22) | 5 | 15 | |
| T3-4 | 70 (77.78) | 40 | 30 | |
| N stage | 0.6726 | |||
| N0-1 | 48 (53.33) | 23 | 25 | |
| N2-3 | 42 (46.67) | 22 | 20 | |
| TNM stage | ||||
| I/II | 35 (38.89) | 12 | 23 | 0.0174 |
| III | 55 (61.11) | 33 | 22 | |
| CEA (ng/ml) | 0.3574 | |||
| <7.2 | 85 (94.44) | 41 | 44 | |
| ≥7.2 | 5 (5.56) | 4 | 1 | |
| CA125 (U/ml) | >0.9999 | |||
| <35 | 83 (92.22) | 41 | 42 | |
| ≥35 | 7 (7.78) | 4 | 3 | |
| CA199 (U/ml) | 0.3343 | |||
| <37 | 79 (87.78) | 38 | 41 | |
| ≥37 | 11 (12.22) | 7 | 4 | |
| Peritoneal metastasis | 0.0243 | |||
| YES | 11 (12.22) | 9 | 2 | |
| NO | 79 (87.78) | 36 | 43 | |